Compared to both OND and HS groups, in MS patients the expression of three proteins (TSLP, IFNβ, and CXCL16) was found to increase, whereas only the sIL-6Rα expression was decreased (Table 1). Here, CXCL16 is linked to myeloid sarcoma.